Nonrulemaking

Patent Term Application for VYALEV (foscarbidopa and foslevodopa), Patent No. 10,174,061

🏛 Food and Drug Administration (FDA)FDA-2025-E-0163

Intellectual Property

Documents

1

Total comments

0

all analyzed

Comment status

Open

Last activity

—

In this docket

Documents

Rules, notices, and supporting material — the primary rule pinned first.

Notice· Jun 29, 2026
Determination of Regulatory Review Period for Purposes of Patent Extension; VYALEV→
Open · 26 days left